We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Oneok
OKE
$57.2B
| $1.66M | 0.01% |
26,840
| – | – |
|
|
GOOS
352
Canada Goose Holdings
GOOS
$898M
| $1.64M | 0.01% |
92,344
-220,631
| -70% | -$3.97M |
|
353
Gilead Sciences
GILD
$166B
| $1.61M | 0.01% |
20,838
| – | – |
|
354
Arcus Biosciences
RCUS
$3.35B
| $1.54M | 0.01% |
75,991
-1,920
| -2% | -$36.6K |
|
355
MP Materials
MP
$6.91B
| $1.51M | 0.01% |
65,972
-12,852
| -16% | -$295K |
|
356
Prothena Corp
PRTA
$441M
| $1.51M | 0.01% |
22,064
+745
| +3% | +$48.1K |
|
|
HLVX
357
DELISTED
HilleVax
HLVX
| $1.5M | 0.01% |
87,043
| – | – |
|
|
RNAM
358
DELISTED
Avidity Biosciences
RNAM
| $1.46M | 0.01% |
131,649
-26,244
| -17% | -$329K |
|
359
Flex
FLEX
$37.8B
| $1.46M | 0.01% |
70,022
| – | – |
|
360
Five Below
FIVE
$11.7B
| $1.45M | 0.01% |
7,399
-19,684
| -73% | -$3.85M |
|
361
XPO
XPO
$23.4B
| $1.42M | 0.01% |
24,118
-8,189
| -25% | -$371K |
|
362
Equinix
EQIX
$99.1B
| $1.39M | 0.01% |
1,776
+390
| +28% | +$286K |
|
363
e.l.f. Beauty
ELF
$4.86B
| $1.38M | 0.01% |
+12,061
| New | +$1.16M |
|
364
General Dynamics
GD
$106B
| $1.37M | 0.01% |
6,349
| – | – |
|
365
Celsius Holdings
CELH
$7.5B
| $1.34M | 0.01% |
+26,895
| New | +$1.07M |
|
366
Newmont
NEM
$93.9B
| $1.33M | 0.01% |
31,158
| – | – |
|
367
Schrodinger
SDGR
$1.12B
| $1.33M | 0.01% |
+26,568
| New | +$898K |
|
368
Axsome Therapeutics
AXSM
$11.8B
| $1.25M | 0.01% |
+17,422
| New | +$1.29M |
|
369
Oscar Health
OSCR
$9.33B
| $1.23M | 0.01% |
+152,933
| New | +$1.13M |
|
370
UFP Technologies
UFPT
$1.97B
| $1.19M | 0.01% |
+6,113
| New | +$946K |
|
371
Carlyle Group
CG
$16.2B
| $1.17M | 0.01% |
36,696
| – | – |
|
372
Doximity
DOCS
$3.93B
| $1.17M | 0.01% |
34,279
-855
| -2% | -$28.5K |
|
|
NSTG
373
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.16M | 0.01% |
287,175
-7,171
| -2% | -$53K |
|
374
Dow Inc
DOW
$21.7B
| $1.13M | 0.01% |
21,158
| – | – |
|
375
GSK
GSK
$107B
| $1.13M | 0.01% |
31,591
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.